title: [Cuprizone early deficits accompanied by specific glial activation implicate pathophysiological changes in schizophrenia].
authors.forename: Tomoaki
authors.initials: T
authors.lastname: Tezuka
authors.forename: Makoto
authors.initials: M
authors.lastname: Tamura
authors.forename: Mari A
authors.initials: MA
authors.lastname: Kondo
authors.forename: M
authors.initials: M
authors.lastname: Sakaue
authors.forename: Kinya
authors.initials: K
authors.lastname: Okada
authors.forename: Kana
authors.initials: K
authors.lastname: Takemoto
authors.forename: Atsushi
authors.initials: A
authors.lastname: Fukunari
authors.forename: Hiroshi
authors.initials: H
authors.lastname: Yasumatsu
authors.forename: Yasushi
authors.initials: Y
authors.lastname: Kajii
mesh_terms: D000818:Animals; D001522:Behavior, Animal / Q000187:drug effects; D003471:Cuprizone / Q000627:therapeutic use*; D008297:Male; D051379:Mice; D008810:Mice, Inbred C57BL; D009457:Neuroglia / Q000187:drug effects*; D009928:Organ Specificity; D012559:Schizophrenia / Q000188:drug therapy* / Q000503:physiopathology
chemical_list: D003471:Cuprizone